View:
Download DOC
Download PDF
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MCCONNELL JOHN P
(Last) (First) (Middle)
1108 SILVER OAKS COURT
(Street)
RALEIGH NC 27614
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALLSCRIPTS HEALTHCARE SOLUTIONS INC [ MDRX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2007 S 30,613 D $25.39(1) 210,950 D
Common Stock 03/05/2007 S 119,387 D $25.39(2) 711,907 I By McConnell Venture Partners Fund, LLC(5)
Common Stock 03/06/2007 S 74,845 D $25.11(3) 136,105 D
Common Stock 03/06/2007 S 291,827 D $25.11(4) 420,080 I By McConnell Venture Partners Fund, LLC(5)
Common Stock 17,622 I By spouse, Catherine Z. McConnell
Common Stock 1,762 I By child, Alexandar Royal McConnell
Common Stock 1,762 I By child, Matthew B. McConnell
Common Stock 1,762 I By child, William A. McConnell
Common Stock 1,762 I By child, Cole B. Olive
Common Stock 1,762 I By child, Kasey L. Olive
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On March 5, 2007, there were multiple sales transactions aggregating 30,613 shares at prices ranging from $25.16 to $25.52, resulting in a weighted average sale price of $25.39.
2. On March 5, 2007, there were multiple sales transactions aggregating 119,387 shares at prices ranging from $25.16 to $25.52, resulting in a weighted average sale price of $25.39.
3. On March 6, 2007, there were multiple sales transactions aggregating 74,845 shares at prices ranging from $25.00 to $25.35, resulting in a weighted average sale price of $25.11.
4. On March 6, 2007, there were multiple sales transactions aggregating 291,827 shares at prices ranging from $25.00 to $25.35, resulting in a weighted average sale price of $25.11.
5. John P. McConnell and Cynthia P. Pittman are the managers of McConnell Venture Partners Fund, LLC.
Jena Kluska for John P. McConnell by Power of Attorney 03/07/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd132525_149106.html 

						       EXHIBIT 24

                            POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes
and appoints each of Jena Kluska, Gina Nienberg, Kathie Kittner, Greg
Swanson and William Davis, signing singly, the undersigned's true and
lawful attorney-in-fact to:
     (1) execute for and on behalf of the undersigned, all reports to be
filed by the undersigned pursuant to Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the rules
promulgated thereunder (including Forms 3, 4, and 5 and any successor forms)
(the "Section 16 Reports") with respect to the equity securities of
Allscripts Healthcare Solutions, Inc. (the "Company");
     (2) do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to complete and execute any
such Section 16 Report, complete and execute any amendment or amendments
thereto, and file such report with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
     (3) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
     The powers granted above may be exercised by each such
attorney-in-fact on behalf of the undersigned, individually, and on behalf of
the undersigned in any fiduciary or representative capacity in which the
undersigned may be acting.
     The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
     This Power of Attorney shall be effective as of the date set forth
below and shall continue in full force and effect until the undersigned is no
longer required to file Section 16 Reports with respect to the equity
securities of the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 7th day of March, 2007.



                                   By:         _____/s/ John P. McConnell_____
                                                          John P. McConnell